Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,956 questions in 143 reviews · Musculoskeletal

current versions
No studies 555 · 28.4%Ungraded 107 · 5.5%Very low 255 · 13%Low 555 · 28.4%Moderate 357 · 18.3%High 127 · 6.5%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
Change in radiographic progression ‐ not measured · patients with treating rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Achievement of low disease state (DAS 28) ‐ not measured · patients with treating rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
ACR 50% improvement ( · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
RR 11.92 [0.73, 193.38]1 study · 23 participantsLow
Intervention NR
Change in pain ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
HAQ disability score ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Patient reported global impression of clinical change (PGIC) 'good' or 'very good' PGIC scale: Very poor, Poor, No change, Good, Very good. · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
RR 1.44 [1.03, 2.03]3 studies · 324 participantsLow
Intervention NR
Withdrawal due to inadequate analgesia · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
RR 0.82 [0.34, 2.01]4 studies · 345 participantsLow
Intervention NR
Functional status (HAQ) HAQ. Scale from: 0 to 3. · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
no estimate extracted2 studies · 243 participantsLow
Intervention NR
Withdrawal due to adverse events · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
RR 2.67 [0.52, 13.75]3 studies · 331 participantsLow
Intervention NR
Participants reporting adverse events · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
OR 3.9 [2.31, 6.56]4 studies · 371 participantsLow
Intervention NR
Serious adverse events · patients with rheumatoid arthritis pain
Opioid therapy for treating rheumatoid arthritis pain (2011) · Cochrane
no estimate extracted2 studies · 317 participantsLow
Intervention NR
Pain ‐ not measured · patients with chronic (>12 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not reported · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disabilty ‐ not measured · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disability DASH scale. Scale from: 0 to 100. ( · patients with chronic (>12 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extracted1 study · 47 participantsLow
Intervention NR
Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain‐ short term VAS scale. Scale from: 0 to 10. ( · patients with lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extracted1 study · 24 participantsModerate
Intervention NR
Pain‐ long term VAS. Scale from: 0 to 10. ( · patients with lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extracted1 study · 24 participantsLow
Intervention NR
Disability Mayo Elbow Performance. Scale from: 0 to 100. ( · patients with lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extracted1 study · 24 participantsLow
Intervention NR
Adverse events ‐ not reported · patients with lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not reported · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disability ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pulmonary Methotrexate pneumonitis · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted2 studies · 27 participantsModerate
Intervention NR
Hepatic Liver histology/hepatic enzyme abnormalities2 · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted2 studies · 272 participantsLow
Intervention NR
Renal Glomerular and tubular injury · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted2 studies · 30 participantsLow
Intervention NR
Haematological Thrombocytopenia · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted0 studies · 1 participantsModerate
Intervention NR
Withdrawal due to adverse events Methotrexate discontinuation · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted3 studies · 632 participantsLow
Intervention NR
All adverse events · patients with inflammatory arthritis on methotrexate
Safety of non‐steroidal anti‐inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people… (2011) · Cochrane
no estimate extracted7 studies · 283 participantsModerate
Tricyclic antidepressant vs control
Pain < 1 week VAS scale 0 to 100 mm · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
no estimate extracted1 study · 30 participantsVery low
Tricyclic antidepressant vs control
Pain 1 to 6 weeks Any pain measurement scale · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
no estimate extracted7 studies · 482 participantsVery low
Tricyclic antidepressant vs control
Pain > 6 weeks Any pain measurement scale · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
no estimate extracted5 studies · 368 participantsVery low
Tricyclic antidepressant vs control
Functional Status Health Assessment Questionnaire (HAQ) scale 0 to 3 · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
no estimate extracted1 study · 28 participantsLow
Tricyclic antidepressant vs control
Number of Withdrawals due to Adverse Events patient interview · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
RR 0.98 [0.59, 1.64]6 studies · 455 participantsVery low
Tricyclic antidepressant vs control
Total number of adverse events patient interview · patients with pain management in RA
Antidepressants for pain management in rheumatoid arthritis (2011) · Cochrane
RR 1.83 [1.01, 3.3]6 studies · 455 participantsVery low
Intervention NR
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted9 studies · 1835 participantsLow
Intervention NR
Function (long term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted4 studies · 1398 participantsHigh
Intervention NR
Adverse events · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Side effects of acupuncture‐Bruising and bleeding at injection site · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Function (short term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted8 studies · 1767 participantsLow
Intervention NR
Pain (long term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted4 studies · 1399 participantsHigh
Intervention NR
Function (long term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted4 studies · 1398 participantsHigh
Intervention NR
Adverse events · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Side effects of acupuncture‐Bruising and bleeding at injection site · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted8 studies · 1773 participantsLow
Intervention NR
Function (short term) WOMAC scale from 0 to 68 points (higher is worse function). · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted8 studies · 1767 participantsLow
Intervention NR
Pain (long term) WOMAC scale from 0 to 20 points (higher is worse pain). · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extracted4 studies · 1399 participantsHigh
Intervention NR
Pain VAS pain scales · Patients with knee osteoarthritis (none of the trials included patients with hip osteoarthritis)
Therapeutic ultrasound for osteoarthritis of the knee or hip (2010) · Cochrane
no estimate extracted5 studies · 320 participantsLow
Intervention NR
Function Various validated function scales · Patients with knee osteoarthritis (none of the trials included patients with hip osteoarthritis)
Therapeutic ultrasound for osteoarthritis of the knee or hip (2010) · Cochrane
no estimate extracted4 studies · 251 participantsLow